Our Services
Medical Information
Helpful Resources
Published on: 11/16/2025
Psoriasis vs. eczema: how to tell the difference
Psoriasis and eczema are both common inflammatory skin conditions, but they have distinct features:
Key clues include distribution, itch severity, nail changes, triggers, and personal or family history. However, only a clinician—sometimes with a skin biopsy—can confirm a diagnosis, and treatments differ significantly between the two.
Because psoriasis and eczema can look alike but require different care, guessing wrong can delay relief. Take a free, instant, online symptom check to better understand your symptoms, identify possible red flags, and confidently plan your next steps.
Reviewed for medical accuracy: 07/09/2026
It's common to see red, scaly, or itchy patches on your skin and wonder if it's plaque psoriasis or eczema (atopic dermatitis). Both conditions can look similar at first glance, but knowing the key signs, causes, and treatments can help you get the right care. Below, we break down the differences, based on clinical data and expert guidance, so you can get closer to an answer—and know when to speak to a doctor.
Plaque psoriasis is a chronic immune-mediated skin disorder. It affects about 2–3% of people worldwide.¹
Key Features
Underlying triggers can include stress, infections, certain medications, and skin injury (Koebner phenomenon).²
Eczema, or atopic dermatitis, is a chronic inflammatory skin condition marked by a "leaky" skin barrier and immune dysregulation. It affects up to 20% of children and 2–10% of adults.³
Key Features
Flares are often triggered by soaps, detergents, dust mites, climate changes, or stress.¹
| Feature | Plaque Psoriasis | Eczema (Atopic Dermatitis) |
|---|---|---|
| Underlying mechanism | T-cell–mediated skin cell overgrowth | Skin barrier defect + immune response |
| Plaque appearance | Thick, raised, silvery scales | Flat to slightly raised, red, dry |
| Itch intensity | Mild to moderate | Often severe ("drives scratching") |
| Typical locations | Extensor surfaces, scalp, nails | Flexural areas, face, hands |
| Age of onset | Any age, peaks in adulthood | Usually childhood, sometimes adults |
| Nail involvement | Common (pitting, onycholysis) | Uncommon |
| Lesion edges | Well-demarcated | Ill-defined, may be oozy or crusted |
| Triggers | Injury, infections, stress, meds | Allergens, irritants, weather, stress |
| Histology | Parakeratosis, elongated rete ridges | Spongiosis, lymphocyte infiltration |
| Chronicity | Lifelong, cyclical flares | Lifelong, cyclic with variable severity |
Inspect the patches
Check distribution
Assess itch severity
Look for associated signs
Consider age and history
Additional testing
Both conditions can impact quality of life, but serious complications can arise:
Speak to a doctor if you have:
If you're experiencing symptoms on your hands—such as redness, itching, or cracked skin—Ubie's free AI-powered hand eczema symptom checker can help you quickly understand what might be causing your discomfort and what to do next.
While both conditions use topical therapies, the specifics differ.
Distinguishing plaque psoriasis from eczema often comes down to the look, feel, and location of your skin lesions—as well as your personal and family history. While online resources can guide you, only a healthcare professional can make a definitive diagnosis. If you're dealing with persistent or puzzling symptoms—especially hand eczema—getting an accurate assessment is the first step toward effective relief and management.
If you notice anything serious—fever, rapid rash spread, signs of infection, severe joint pain—please speak to a doctor right away. Proper diagnosis and early treatment can help you manage symptoms, reduce flares, and improve your quality of life.
Footnotes
(References)
Weidinger S, & Novak N. (2016). Atopic dermatitis. Lancet, 26803312.
Christophers E. (2001). Psoriasis—epidemiology and clinical spectrum. Clin Dermatol, 11731473.
Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, & ter Borg PC. (2000). A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology, 10927761.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.